These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9658370)
1. Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B. Lok AS; Ghany MG; Watson G; Ayola B J Viral Hepat; 1998 May; 5(3):171-8. PubMed ID: 9658370 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of changes in serum hepatitis B virus DNA titer in patients with chronic hepatitis B treated with interferon. Hwang SJ; Lu RH; Wang YJ; Chu CW; Wu JC; Chang FY; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):1-7. PubMed ID: 10645044 [TBL] [Abstract][Full Text] [Related]
3. Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa. Buster EH; Hansen BE; Lau GK; Piratvisuth T; Zeuzem S; Steyerberg EW; Janssen HL Gastroenterology; 2009 Dec; 137(6):2002-9. PubMed ID: 19737568 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of granulocyte-macrophage colony-stimulating factor or lamivudine combination with recombinant interferon in non-responders to interferon in hepatitis B virus-related chronic liver disease patients. Guptan RC; Thakur V; Kazim SN; Sarin SK J Gastroenterol Hepatol; 2002 Jul; 17(7):765-71. PubMed ID: 12121506 [TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon-alpha. Habersetzer F; Zoulim F; Jusot JF; Zhang X; Trabaud MA; Chevallier P; Chevallier M; Ahmed SN; Sepetjan M; Comanor L; Minor J; Trépo C J Viral Hepat; 1998 Nov; 5(6):407-14. PubMed ID: 9857350 [TBL] [Abstract][Full Text] [Related]
6. HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Wai CT; Chu CJ; Hussain M; Lok AS Hepatology; 2002 Dec; 36(6):1425-30. PubMed ID: 12447868 [TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B. Piccolo P; Lenci I; di Paolo D; Demelia L; Sorbello O; Nosotti L; Angelico M Antivir Ther; 2013; 18(1):57-64. PubMed ID: 22872648 [TBL] [Abstract][Full Text] [Related]
8. Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients. Yeh ML; Peng CY; Dai CY; Lai HC; Huang CF; Hsieh MY; Huang JF; Chen SC; Lin ZY; Yu ML; Chuang WL PLoS One; 2015; 10(4):e0122259. PubMed ID: 25835020 [TBL] [Abstract][Full Text] [Related]
9. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial. Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905 [TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha treatment in children and young adults with chronic hepatitis B: a long-term follow-up study in Taiwan. Hsu HY; Tsai HY; Wu TC; Chiang CL; Ni YH; Chen PJ; Chang MH Liver Int; 2008 Nov; 28(9):1288-97. PubMed ID: 18397229 [TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007 [TBL] [Abstract][Full Text] [Related]
12. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B. Tangkijvanich P; Komolmit P; Mahachai V; Sa-nguanmoo P; Theamboonlers A; Poovorawan Y J Clin Virol; 2009 Oct; 46(2):117-23. PubMed ID: 19651540 [TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of serum hepatitis B e antigen, IgM hepatitis B core antibody and HBV DNA in monitoring the response to treatment in patients with chronic hepatitis B. Bernard F; Raymond G; Willems B; Villeneuve JP J Viral Hepat; 1997 Jul; 4(4):265-72. PubMed ID: 9278224 [TBL] [Abstract][Full Text] [Related]
14. Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses. Guptan RC; Thakur V; Raina V; Sarin SK J Gastroenterol Hepatol; 1999 Sep; 14(9):893-8. PubMed ID: 10535471 [TBL] [Abstract][Full Text] [Related]
15. ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B. ter Borg MJ; Hansen BE; Bigot G; Haagmans BL; Janssen HL J Clin Virol; 2008 Jun; 42(2):160-4. PubMed ID: 18359663 [TBL] [Abstract][Full Text] [Related]
16. Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia? Nair S; Perrillo RP Hepatology; 2001 Nov; 34(5):1021-6. PubMed ID: 11679974 [TBL] [Abstract][Full Text] [Related]
17. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients. Cotonat T; Quiroga JA; López-Alcorocho JM; Clouet R; Pardo M; Manzarbeitia F; Carreño V Hepatology; 2000 Feb; 31(2):502-6. PubMed ID: 10655277 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic vaccination in chronic hepatitis B. Senturk H; Tabak F; Akdogan M; Erdem L; Mert A; Ozaras R; Sander E; Ozbay G; Badur S J Gastroenterol Hepatol; 2002 Jan; 17(1):72-6. PubMed ID: 11895556 [TBL] [Abstract][Full Text] [Related]
19. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946 [TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B. Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]